Cognitive reappraisal self-efficacy mediates the effects of individual cognitive-behavioral therapy for social anxiety disorder.

Journal of Consulting and Clinical Psychology
Philippe R GoldinJames J Gross

Abstract

To examine whether changes in cognitive reappraisal self-efficacy (CR-SE) mediate the effects of individually administered cognitive-behavioral therapy (I-CBT) for social anxiety disorder (SAD) on severity of social anxiety symptoms. A randomized controlled trial in which 75 adult patients (21-55 years of age; 53% male; 57% Caucasian) with a principal diagnosis of generalized SAD were randomly assigned to 16 sessions of I-CBT (n = 38) or a wait-list control (WL) group (n = 37). All patients completed self-report inventories measuring CR-SE and social anxiety symptoms at baseline and post-I-CBT/post-WL, and I-CBT completers were also assessed at 1-year posttreatment. Compared with WL, I-CBT resulted in greater increases in CR-SE and greater decreases in social anxiety. Increases in CR-SE during I-CBT mediated the effect of I-CBT on social anxiety. Gains achieved by patients receiving I-CBT were maintained 1-year posttreatment, and I-CBT-related increases in CR-SE were also associated with reduction in social anxiety at the 1-year follow-up. Increasing CR-SE may be an important mechanism by which I-CBT for SAD produces both immediate and long-term reductions in social anxiety.

References

Mar 1, 1977·Psychological Review·A Bandura
Sep 29, 2000·The American Journal of Psychiatry·M B Stein, Y M Kean
Jun 2, 2001·Journal of Clinical Psychopharmacology·I C Fedoroff, S Taylor
Jun 8, 2002·Behaviour Research and Therapy·Sandra L BakerStefan G Hofmann
Jun 11, 2003·Child Development·Albert BanduraConcetta Pastorelli
Aug 14, 2003·Behaviour Research and Therapy·U StangierD M Clark
Aug 15, 2003·Journal of Personality and Social Psychology·James J Gross, Oliver P John
Sep 3, 2003·Acta Psychiatrica Scandinavica. Supplementum·M B Keller
Nov 19, 2003·Journal of Consulting and Clinical Psychology·David M ClarkBeverley Louis
Jul 29, 2004·Journal of Consulting and Clinical Psychology·Stefan G Hofmann
Feb 7, 2006·Behaviour Research and Therapy·Thomas L Rodebaugh
Jul 11, 2006·Journal of Consulting and Clinical Psychology·David M ClarkJennifer Wild
Dec 13, 2006·Journal of Consulting and Clinical Psychology·Jasper A J SmitsMichael J Telch
Apr 1, 2008·Lancet·Murray B Stein, Dan J Stein
May 3, 2008·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Helena Chmura KraemerDavid J Kupfer
Nov 18, 2008·Journal of Affective Disorders·C AcarturkP Cuijpers
Mar 3, 2009·Cyberpsychology & Behavior : the Impact of the Internet, Multimedia and Virtual Reality on Behavior and Society·Sophie Côté, Stéphane Bouchard
Jun 9, 2009·Scandinavian Journal of Psychology·Petra Thomasson, Elia Psouni
Sep 1, 2009·Biological Psychiatry·Philippe R GoldinJames J Gross
Nov 7, 2009·Behavior Therapy·Deborah Roth LedleyDavid M Fresco
Apr 20, 2010·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Nina RottmannChristoffer Johansen
Jun 3, 2010·Journal of Consulting and Clinical Psychology·Eric C Odgaard, Robert L Fowler
Aug 20, 2010·The International Journal of Eating Disorders·Anna L SteeleTracey D Wade
Aug 19, 2011·Addictive Behaviors·Ronald M Kadden, Mark D Litt

❮ Previous
Next ❯

Citations

May 16, 2012·Social Cognitive and Affective Neuroscience·Philippe GoldinJames J Gross
Jun 12, 2014·PloS One·Benjamin KreifeltsDirk Wildgruber
Jan 7, 2014·Annual Review of Clinical Psychology·Aaron T Beck, Emily A P Haigh
Jul 2, 2014·Journal of Anxiety Disorders·Judy WongJames J Gross
Mar 30, 2013·Annual Review of Clinical Psychology·Amanda S Morrison, Richard G Heimberg
Dec 3, 2014·Journal of Behavior Therapy and Experimental Psychiatry·Jens BlechertJames J Gross
Jan 19, 2016·Frontiers in Psychology·Olga Gómez-OrtizPablo Fernández-Berrocal
Apr 25, 2013·Behavior Therapy·Douglas S MenninJames J Gross
Oct 14, 2014·Clinical Psychology & Psychotherapy·Mia S O'TooleNicole K Rosenberg
Nov 4, 2015·Frontiers in Behavioral Neuroscience·Armin ZlomuzicaJürgen Margraf
May 25, 2012·Journal of Clinical Psychology·Hooria JazaieriJames J Gross
Mar 26, 2014·Pediatric Blood & Cancer·Vikki G NolanKirsten K Ness
Jun 20, 2014·International Journal of Methods in Psychiatric Research·Helena Chmura Kraemer
Jun 22, 2013·Journal of Behavior Therapy and Experimental Psychiatry·David A MoscovitchDubravka L Gavric
Jul 30, 2015·Cognition & Emotion·Yochanan E BigmanMaya Tamir
Apr 11, 2015·Current Opinion in Psychology·Kim L GratzMatthew T Tull
Jul 23, 2013·Journal of Psychiatric Research·Jasper A J SmitsStefan G Hofmann
Jan 6, 2015·Comprehensive Psychiatry·Iulian IancuItzhak Z Ben-Zion
Nov 8, 2014·Cognitive Behaviour Therapy·Krista De CastellaJames J Gross
Nov 22, 2014·Current Psychiatry Reports·Hooria JazaieriJames J Gross
May 2, 2016·Journal of Behavior Therapy and Experimental Psychiatry·Kirsten BarnicotStefan Priebe
Jul 13, 2016·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Sheung-Tak ChengLinda C W Lam
Jul 29, 2016·Journal of Anxiety Disorders·Shaun B Pearl, Peter J Norton
Oct 8, 2016·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Pim CuijpersMarcus J H Huibers
Jul 1, 2013·Clinical Psychological Science : a Journal of the Association for Psychological Science·Philippe R GoldinJames J Gross
Oct 16, 2016·Psychological Science·Simon J HainesPeter Koval
Apr 13, 2017·Psychology & Health·Daniel O'LearyJames J Gross
Jul 27, 2017·Behavior Modification·Carol S Lee, Sarah A Hayes-Skelton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.